AAPM&R Submits Comments on Adoption and Use of AI
Botulinum Toxin LCD – Reminder Regarding Spasticity Assessment
Drs. Khwarg and Cowling Featured in the Media
Dr. Khwarg Featured in the Media
Dr. Espiritu McKay Featured in the Media
Incentives Restored for Advanced Alternative Payment Model Participants
Telehealth Flexibilities Extended Through December 31, 2027
Dr. Adam Tenforde Featured in the Media
Dr. Jason Zaremski Featured in the Media
CMS Releases List of Participants for Ambulatory Specialty Model – Low Back Pain
Matthew Smuck Featured in the Media
AAPM&R Advocacy Win! Medicare Contractors Finalize Comprehensive Botulinum Toxin Policy Aligned with Academy Advocacy Efforts and Valuable Member Input
Prepare for the CMS Cost Measure Field Testing Period: Parkinsonism Syndromes and Multiple Sclerosis
Tracy Espiritu McKay Featured in the Media
Michael Fredericson Featured in the Media
Abby Cheng Featured in the Media
AAPM&R Opposes Announced CMS Expansion of the IRF Review Choice Demonstration to Texas and California in 2026
Brush Up on Coding with a New AAPM&R Resource
Following Productive Dialogue with AAPM&R, Novitas and First Coast Finalize Requested Updates to Botulinum Toxin Coding and Billing Article